AWL-II-38.3

CAS No. 1135205-94-5

AWL-II-38.3( —— )

Catalog No. M28187 CAS No. 1135205-94-5

AWL-II-38.3 is a potent ephrin-A receptor (EphA3) kinase inhibitor. AWL-II-38.3 does not exhibit significant cellular activity against Src-family kinases nor against b-raf.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 160 Get Quote
10MG 250 Get Quote
25MG 515 Get Quote
50MG 740 Get Quote
100MG 1017 Get Quote
500MG 2052 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    AWL-II-38.3
  • Note
    Research use only, not for human use.
  • Brief Description
    AWL-II-38.3 is a potent ephrin-A receptor (EphA3) kinase inhibitor. AWL-II-38.3 does not exhibit significant cellular activity against Src-family kinases nor against b-raf.
  • Description
    AWL-II-38.3 is a potent ephrin-A receptor (EphA3) kinase inhibitor. AWL-II-38.3 does not exhibit significant cellular activity against Src-family kinases nor against b-raf.(In Vitro):AWL-II-38.3 fits to LIMK2 and LIMK1 ATP-binding and substrate-binding pockets .
  • In Vitro
    AWL-II-38.3 fits to LIMK2 and LIMK1 ATP-binding and substrate-binding pockets.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Tyrosine Kinase
  • Target
    Ephrin Receptor
  • Recptor
    PEGs
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1135205-94-5
  • Formula Weight
    469.42
  • Molecular Formula
    C23H18F3N5O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 66.67 mg/mL (142.03 mM)
  • SMILES
    CC1=CN(C=N1)C1=CC(=CC(=C1)C(F)(F)F)C(=O)NC1=CC=C(C)C(NC(=O)C2=CC=NO2)=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
molnova catalog
related products
  • 123C4

    123C4 is a potent, selective and competitive agonist of the receptor tyrosine kinase?EPHA4 (Ki=0.65 μM).

  • UniPR505

    UniPR505 is a potent EphA2 antagonist (IC50: 0.95 μM), a novel 3α-carbamoyloxy derivative with antiangiogenic properties.

  • AI-10-49

    AI-10-49 is a selective inhibitor of the binding of CBFβ-SMMHC to RUNX1 with IC50 of 260 nM.